Company Filing History:
Years Active: 1998-1999
Title: Colvin M Redman: Innovator in Diagnostic Antibody Development
Introduction
Colvin M Redman is a notable inventor based in Franklin Square, NY (US). He has made significant contributions to the field of diagnostics through his innovative inventions. With a total of 2 patents, Redman has focused on developing advanced methods for detecting specific biomarkers in biological samples.
Latest Patents
Redman's latest patents include a groundbreaking invention related to monospecific antibodies reactive with fibrinogen and fibrinopeptide B. This invention provides antibodies that are specifically reactive with fibrinopeptide B (FPB) and with fibrinogen and its fragments. The invention also includes anti-FPB probes, which are detectably labeled monospecific anti-FPB antibodies. Furthermore, it outlines methods for using these antibodies to detect fibrinopeptide B in biological samples, such as blood, which can aid in diagnosing conditions related to atherogenesis and thrombogenesis. Another significant patent focuses on a diagnostic method for determining Kell blood group genotype. This method accurately identifies the molecular basis of a Kell polymorphism, employing amplification of K1/K2 nucleic acid sequences and differential cleavage by restriction enzymes. Diagnostic kits for determining Kell genotype are also provided in this invention.
Career Highlights
Colvin M Redman is associated with the New York Blood Center, Inc., where he applies his expertise in antibody development and diagnostics. His work has contributed to advancements in medical diagnostics, particularly in the areas of blood group genotyping and biomarker detection.
Collaborations
Redman has collaborated with notable colleagues, including Bohdan J Kudryk and Jian-Zhong Zhang. These collaborations have further enhanced the impact of his inventions in the field of diagnostics.
Conclusion
Colvin M Redman is a distinguished inventor whose work in developing diagnostic antibodies has the potential to significantly improve medical diagnostics. His innovative patents reflect a commitment to advancing healthcare through technology.